Loading data for PROF — first visit, this takes a few seconds.

提醒

Profound Medical Corp. (PROF)

NasdaqCM: PROF · 即時價格 · USD

6.84

+0.05 (0.74%)

收盤價： Aug 25, 2026, 7:05 PM

股價、關鍵數字和最新消息，都在這一頁。

0.74% (1D)

無可用資料

買價	5
市值	249.52M
營收 (ttm)	19.09M
淨利（ttm）	-32.74M
	0.53
	-0.99
	n/a
	-11.62
P/B (ttm)	4.18
P/S (ttm)	13.07
財報日期	Nov 12, 2026

賣價	8.81
成交量	43,010
20 日平均成交量	92,830
開盤價	6.80
前收盤價	6.79
當日區間	6.80 - 7.08
52 週範圍	3.76 - 8.95
分析師	n/a
目標價	n/a
股利	n/a
除息日	n/a

關於 PROF

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defi...

[閱讀更多]

產業 Medical Devices

類股 Healthcare

IPO 日期 Oct 29, 2019

員工 162

證券交易所 NasdaqCM

股票代號 PROF

網站 https://www.profoundmedical.com

完整的公司簡介

財務表現

Profound Medical 在 2025 年的營收為 16.1M，較前一年的 10.68M 增加 50.73%。淨利為 -42.57M，較前期增加 53.04%。

財務報表

財報驚奇

Profound Medical 已於 Aug 6, 2026 公布季度財報：

營收為 $2.48M 低於預期 $0, 年增 12.30% 成長.
每股盈餘為 -0.26 低於預期 -0.02, 年增 50.00% 成長.

下次財報發布

Profound Medical Corp. 的下次財報預計於 Nov 12, 2026, 盤中。
分析師預估營收 ... 升級

新聞動態

1 週前 · Motley Fool

Profound Medical (PROF) Q2 2026 Earnings Call Transcript

Record orders and expanding payer coverage mark commercial inflection.

2 週前 · Moby

Profound Medical Corp. Q2 2026 Earnings Call Summary

Moby summary of Profound Medical Corp.'s Q2 2026 earnings call

2 週前 · MarketBeat

Profound Medical Q2 Earnings Call Highlights

Profound Medical (NASDAQ:PROF) reported second-quarter 2026 revenue of CAD 2.5 million, up 12% from CAD 2.2 million a year earlier, as the company said the reported figure was affected by the timing o...

2 週前 · GuruFocus.com

Profound Medical Corp (PROF) (Q2 2026) Earnings Call Highlights: Record Orders and ...

Despite a $3.1 million shipment timing issue, Profound Medical Corp (PROF) posts strong commercial momentum with a record July order month and expanding payer coverage.

2 週前 · Zacks

Profound Medical (PROF) Q2 Earnings Surpass Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of +218.18% and -55.66%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

第 1 頁，共 2 頁

Profound Medical Corp. (PROF)